Mwanzo2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Bei iliyotangulia
$ 13.76
Bei za siku
$ 13.84 - $ 14.04
Bei za mwaka
$ 11.52 - $ 19.50
Thamani ya kampuni katika soko
61.24B HKD
Wastani wa hisa zilizouzwa
5.41M
Uwiano wa bei na mapato
12.63
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 9.42B | -7.26% |
Matumizi ya uendeshaji wa biashara | 3.85B | -6.02% |
Mapato halisi | 764.76M | 25.42% |
Kiwango cha faida halisi | 8.12 | 35.33% |
Mapato kwa kila hisa | — | — |
EBITDA | 1.28B | -22.50% |
Asilimia ya kodi ya mapato | 30.13% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 16.07B | 6.98% |
Jumla ya mali | 117.99B | 3.73% |
Jumla ya dhima | 57.14B | 1.66% |
Jumla ya hisa | 60.85B | — |
hisa zilizosalia | 2.64B | — |
Uwiano wa bei na thamani | 0.76 | — |
Faida inayotokana na mali | 1.37% | — |
Faida inayotokana mtaji | 1.68% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 764.76M | 25.42% |
Pesa kutokana na shughuli | 1.06B | 15.08% |
Pesa kutokana na uwekezaji | -185.09M | 84.46% |
Pesa kutokana na ufadhili | -633.63M | -742.38% |
Mabadiliko halisi ya pesa taslimu | 245.87M | 262.03% |
Mtiririko huru wa pesa | -1.89B | -2.13% |
Kuhusu
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1994
Tovuti
Wafanyakazi
40,557
